The androgen receptor independent mechanism of toxicity of the novel anti-tumor agent 11[beta]-dichloro

Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Biological Engineering, 2009.

Bibliographic Details
Main Author: Fedeleş, Bogdan I
Other Authors: John M. Essigmann.
Format: Thesis
Language:eng
Published: Massachusetts Institute of Technology 2011
Subjects:
Online Access:http://hdl.handle.net/1721.1/61222
_version_ 1826192631856627712
author Fedeleş, Bogdan I
author2 John M. Essigmann.
author_facet John M. Essigmann.
Fedeleş, Bogdan I
author_sort Fedeleş, Bogdan I
collection MIT
description Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Biological Engineering, 2009.
first_indexed 2024-09-23T09:26:22Z
format Thesis
id mit-1721.1/61222
institution Massachusetts Institute of Technology
language eng
last_indexed 2024-09-23T09:26:22Z
publishDate 2011
publisher Massachusetts Institute of Technology
record_format dspace
spelling mit-1721.1/612222019-04-10T13:19:54Z The androgen receptor independent mechanism of toxicity of the novel anti-tumor agent 11[beta]-dichloro AR independent mechanism of toxicity of the novel anti-tumor agent 11[beta]-dichloro multifaceted toxicological puzzle : investigating the androgen receptor independent cellular responses to the novel anti-tumor agent 11[beta]-dichloro Fedeleş, Bogdan I John M. Essigmann. Massachusetts Institute of Technology. Dept. of Biological Engineering. Massachusetts Institute of Technology. Dept. of Biological Engineering. Biological Engineering. Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Biological Engineering, 2009. In title on title-page "[beta]" appears as the lower-case Greek letter. Vita. Page 284 blank. Cataloged from PDF version of thesis. Includes bibliographical references. Inspired by the toxicity mechanism of cisplatin in testicular cancer, a series of bi-functional genotoxicants has been designed that supplement their DNA damaging properties with the ability to interact with tumor specific proteins. One such compound, 11[beta] -dichloro links an aniline mustard moiety to a steroid ligand for the androgen receptor (AR). In vitro and in vivo (cell cultures, mouse xenografts) studies highlighted the potent antitumor properties of the molecule, which can prevent growth of AR positive tumor xenografts in mice. However, 11 p-dichloro also proved highly effective against many cancer lines that do not express the AR, more so than other nitrogen mustards commonly used in chemotherapy. To understand better the AR independent mechanism, the toxicity of 116 -dichloro was investigated in Saccharomyces cerevisiae, by interrogating the complete yeast single-gene deletion mutant library. Surprisingly, the screen revealed that the mutants most sensitive to 11[beta] -dichloro are not the ones lacking genes involved in DNA repair, but rather mutants lacking genes involved in mitochondrial and ribosomal function. While some of the sensitive mutants are also sensitive to other DNA damaging agents, almost half of them are uniquely sensitive to 11[beta] -dichloro, suggesting a DNA-damage independent mechanism of action. Based on the yeast findings, we tested mechanistic hypotheses in HeLa cells (an AR negative human cancer cell line), and discovered that 11[beta] -dichloro induces a large amount of reactive oxygen species (ROS), accompanied by a significant depletion of the antioxidant pool and a perturbation of the mitochondrial inner membrane potential. We also discovered that cotreatment with antioxidants such as N-acetyl cysteine or vitamin E alleviates the toxicity of 11[beta]-dichloro, suggesting that ROS play an important role in the mechanism of toxicity. In terms of transcriptional responses, previous observations were confirmed that 11[beta] -dichloro upregulates expression of genes involved in the unfolded protein response (UPR) and sterol biosynthesis. Additional cellular responses consistent with these pathways were the striking increase in cytosolic calcium and significant changes in the size of the cells. Taken together, our results highlight the multifaceted toxicological profile of 11[beta] -dichloro, indicating that besides DNA damage, the generation of ROS and induction of UPR may be the additional pathways responsible for the potent anticancer effects of this agent. by Bogdan I. Fedeleş. Ph.D. 2011-02-23T14:31:55Z 2011-02-23T14:31:55Z 2009 2009 Thesis http://hdl.handle.net/1721.1/61222 701394975 eng MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission. http://dspace.mit.edu/handle/1721.1/7582 284 p. application/pdf Massachusetts Institute of Technology
spellingShingle Biological Engineering.
Fedeleş, Bogdan I
The androgen receptor independent mechanism of toxicity of the novel anti-tumor agent 11[beta]-dichloro
title The androgen receptor independent mechanism of toxicity of the novel anti-tumor agent 11[beta]-dichloro
title_full The androgen receptor independent mechanism of toxicity of the novel anti-tumor agent 11[beta]-dichloro
title_fullStr The androgen receptor independent mechanism of toxicity of the novel anti-tumor agent 11[beta]-dichloro
title_full_unstemmed The androgen receptor independent mechanism of toxicity of the novel anti-tumor agent 11[beta]-dichloro
title_short The androgen receptor independent mechanism of toxicity of the novel anti-tumor agent 11[beta]-dichloro
title_sort androgen receptor independent mechanism of toxicity of the novel anti tumor agent 11 beta dichloro
topic Biological Engineering.
url http://hdl.handle.net/1721.1/61222
work_keys_str_mv AT fedelesbogdani theandrogenreceptorindependentmechanismoftoxicityofthenovelantitumoragent11betadichloro
AT fedelesbogdani arindependentmechanismoftoxicityofthenovelantitumoragent11betadichloro
AT fedelesbogdani multifacetedtoxicologicalpuzzleinvestigatingtheandrogenreceptorindependentcellularresponsestothenovelantitumoragent11betadichloro
AT fedelesbogdani androgenreceptorindependentmechanismoftoxicityofthenovelantitumoragent11betadichloro